CGTX

CGTX

USD

Cognition Therapeutics Inc. Common Stock

$0.317+0.002 (0.698%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$0.315

最高

$0.315

最低

$0.306

交易量

0.54M

公司基本面

市值

19.7M

行業

生物科技

國家

United States

交易統計

平均交易量

1.07M

交易所

NCM

貨幣

USD

52週範圍

最低 $0.222當前 $0.317最高 $2.535

相關新聞

GlobeNewswire

Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,

查看更多
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
GlobeNewswire

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies

PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released

查看更多
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.

查看更多
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3